Nano-liposomes are vesicular lipid-based nanocarriers widely studied for drug delivery, model encapsulation, vaccine research, cosmetic delivery systems, and controlled-release formulation development. This protocol presents a Protoly-managed and partially NSL-supported workflow for preparing nano-liposome dispersions using controlled hydration, mixing, mild heating, waiting, and sonication-assisted size reduction.
In this workflow, a lipid phase or pre-prepared lipid film is hydrated using an aqueous phase delivered through reservoir dispensing. A safe model payload may be included in the hydration medium to represent drug loading in a non-clinical demonstration format. The mixture is stirred under controlled conditions and thermally supported at mild temperature to assist lipid hydration and vesicle formation. Sonication may then be applied to reduce larger vesicles and improve dispersion uniformity. The final dispersion is visually documented using chamber illumination and camera support before manual collection for external characterization.
The protocol is designed to show how a conventional liposome preparation workflow can be converted into a structured protocol suitable for automation-assisted execution. NSL-supported steps improve repeatability in liquid addition, hydration time, mixing speed, temperature exposure, and sonication duration. Offline characterization such as particle size analysis, zeta potential measurement, encapsulation efficiency, release study, and biological evaluation should be conducted separately. This protocol is suitable for educational demonstration, nanocarrier formulation screening, and early-stage drug delivery model studies.
Liposomes are spherical vesicles composed of lipid bilayers that can encapsulate aqueous compounds inside their internal core and associate hydrophobic compounds within the lipid bilayer. Because of this structure, liposomes are widely studied as model carriers for drug delivery, vaccine formulation, nutraceutical delivery, cosmetic actives, imaging agents, and controlled-release systems.
The preparation of liposomes is highly dependent on formulation and processing conditions. Lipid composition, hydration medium, temperature, stirring time, sonication time, lipid concentration, payload type, and post-processing method can strongly influence vesicle size, dispersion stability, loading behaviour, and appearance. In manual preparation, these variables may change from batch to batch because hydration, mixing, and sonication are often performed with operator-dependent timing and handling.
Protoly can organize this workflow into a structured sequence of formulation steps, while the NSL platform can support selected physical operations such as reservoir dispensing, stirring, heating, waiting, sonication, illumination, camera recording, exhaust control, and environment sensing. This makes the protocol suitable for demonstrating how lipid-based nanocarrier preparation can be made more systematic and better documented.
This protocol focuses on the preparation of nano-liposome dispersions for drug delivery model development. It may use a safe model payload rather than an actual therapeutic drug so that the workflow remains suitable for educational and early research demonstration. The final liposome dispersion should be characterized separately using suitable external methods such as particle size analysis, zeta potential, microscopy, encapsulation efficiency, release studies, and stability evaluation.
Visible LED illumination control
Camera data acquisition with video and interval snapshots
Environment Sensors module step
Timed UV sterilization cycle
Place the pre-prepared lipid film, lipid concentrate, or lipid stock dispersion into the hydration vessel before starting the automated run. If a thin-film method is used, solvent evaporation and drying should be completed externally before placing the vessel in the NSL system.
Dispense the hydration medium into the vessel containing the lipid phase or lipid film. This step initiates lipid hydration and supports vesicle formation.
Add a safe model payload solution to demonstrate liposome-based loading or carrier development. For general demonstration, use a coloured or fluorescent model compound instead of a therapeutic drug.
Magnetic stirrer control module
Temperature control module for heating processes
Delay or hold step
Magnetic stirrer control module
Add a stabilizer or cryoprotectant solution if required by the formulation design. This may help improve dispersion stability or prepare the liposome sample for later storage studies.
Magnetic stirrer control module
Sonicator Bath Heater module step
Delay or hold step
Use exhaust control when required during formulation handling, especially if lipid stock preparation involved residual volatile components. Any solvent-handling step should be performed externally with proper safety arrangements.
If required, remove unencapsulated payload using external purification methods such as centrifugation, dialysis, size-exclusion separation, or filtration. This step is not an NSL module and should be documented as an external process.
This protocol demonstrates how liposome preparation can be converted into a structured automation-assisted workflow. Liposome formation is sensitive to lipid composition, hydration medium, temperature, hydration time, mixing intensity, sonication duration, and payload compatibility. In manual preparation, these variables may be handled inconsistently, which can affect vesicle size, dispersion stability, visual appearance, encapsulation behaviour, and batch reproducibility.
The use of Protoly helps organize the workflow into clearly defined preparation steps. The NSL platform can support important physical actions such as dispensing hydration medium, adding model payload solution, stirring, heating, waiting, sonication, chamber illumination, camera documentation, exhaust operation, and environment recording. This makes the process easier to repeat and compare between formulation batches.
A major advantage of this protocol is its suitability for drug delivery model demonstrations. Instead of using an actual therapeutic drug, a safe model payload can be used to explain how a compound may be incorporated into or associated with lipid vesicles. This makes the protocol useful for teaching, webinar demonstration, and early nanocarrier formulation screening.
The workflow is also useful for formulation iteration. Different lipid compositions, lipid-to-cholesterol ratios, hydration temperatures, sonication durations, stabilizer levels, and payload types can be compared systematically. The visual appearance and offline characterization results can then be linked with the recorded preparation conditions.
However, this protocol has important limitations. The NSL-supported workflow can assist with hydration, mixing, heating, and sonication, but it does not independently confirm nanoscale size, encapsulation efficiency, release profile, sterility, toxicity, or biological performance. Liposome quality must be verified using external methods such as DLS, zeta potential analysis, microscopy, fluorescence or absorbance-based payload estimation, dialysis release studies, and stability testing.
The prepared dispersion should therefore be considered a research or educational prototype, not a validated pharmaceutical liposome formulation. Further development would require optimized lipid composition, controlled purification, validated analytical methods, biological testing, long-term stability assessment, and regulatory review.
Overall, this protocol provides a practical example of how Protoly can manage a partially NSL-supported nanocarrier formulation workflow. It connects lipid-based drug delivery concepts with automation-assisted preparation, structured documentation, and future data-driven formulation optimization.
| S. No. | Compound Type | Possible Location in Liposome |
|---|---|---|
| 1 | Water-soluble compound | Aqueous core |
| 2 | Hydrophobic compound | Lipid bilayer |
| 3 | Amphiphilic compound | Bilayer interface |
| 4 | Fluorescent marker | Depending on solubility and charge |
| 5 | Model drug | Carrier demonstration |
This protocol presents an automation-assisted method for preparing nano-liposome dispersions as a drug delivery model system. Using Protoly and selected NSL modules, the workflow supports controlled hydration medium dispensing, model payload addition, stirring, mild heating, waiting, sonication, illumination, camera documentation, and environmental condition recording.
The main value of this protocol is that it converts a manually variable liposome preparation process into a structured and documented workflow. It is suitable for educational demonstration, nanocarrier formulation screening, drug delivery model studies, and early-stage product-development training.
The final liposome dispersion should be treated as a research prototype only. External characterization, including particle size analysis, zeta potential, encapsulation efficiency, release study, stability testing, sterility assessment, and biological evaluation, is required before any advanced biomedical or formulation application can be considered.